Skip to main content
Welcome to Deloitte

If we have selected the wrong experience for you, please change it above.

Unlocking the new window for digital health in the Swiss Health Valley

A joint report by BioAlps and Deloitte exploring how digital innovation can help address some of healthcare’s major challenges, and what is needed to translate its potential into routine care.

Digital health is entering a new phase. Mounting pressure on healthcare systems and a more enabling policy and data environment are converging. Together, these forces are creating a window to move beyond stand-alone applications, pilots and siloed data towards digital infrastructure embedded in routine clinical workflows. The opportunity for the Swiss Health Valley (Western Switzerland) is to convert the region’s strong research base and early-stage innovation into commercially scalable digital solutions that can be integrated into clinical workflows and adopted across the healthcare system.

The new phase for digital health

Across the world, healthcare systems face growing pressure to deliver more care with constrained resources. By 2030 one in six people worldwide will be aged 60 or older and the global shortfall in healthcare workers is projected to reach 11 million.[1][2] These pressures are accelerating demand for digital solutions that support prevention, clinical productivity and more personalised care. Digital health is advancing beyond standalone technologies towards solutions that support earlier diagnosis, more personalised treatment and care beyond hospital walls.

Western Switzerland offers a compact setting in which to examine how digital innovation can respond to these pressures. Its 215 digital health technology companies, more than 70 academic and research institutions, and university hospitals bring different parts of the innovation pathway into close proximity.[3]

Four digital trends on the move in the region

Drawing on interviews with key industry stakeholders, we explore four global trends that are reshaping digital health, with Western Switzerland providing compelling examples of innovation in each area.

1. Wearables as monitors and digital biomarkers

Shift from occasional health measurements to continuous monitoring and personalised guidance.

Example

CSEM is combining patient monitoring with an AI-powered assistant to manage hypertension.

2. Clinical AI in workflow-embedded diagnosis

Progression towards multimodal diagnosis and clinically validated tools that support more precise treatment decisions.

Example

BrainQuant is developing quantitative MRI software supporting neurological diagnosis and monitoring contributing to advances in multimodal diagnosis.

3. Genomics and multimodal data for personalised medicine

Shift towards integrated patient data to better predict disease progression and treatment response.

Example

SOPHiA GENETICS is using AI-powered genomic analysis and genomic data to support more personalised treatment decisions.

4. Neurotechnology that can restore mobility

Restoring neurological function through stimulation and expanding rehabilitation through scalable digital therapies.

Example

MindMaze Therapeutics is developing digital therapies for personalised neurorehabilitation in hospitals and at home Onward Medical develops spinal-cord stimulation therapies to restore hand function and sensation after injury.

Turning digital health innovation into clinical impact

Building on Western Switzerland’s strong digital health innovation ecosystem, three priorities emerge to accelerate clinical adoption and sustainable growth.

 

 

Western Switzerland offers a compact setting in which to test these changes across a small number of institutions. Initial projects should establish whether shared processes shorten data-access times, help providers make purchasing decisions and reduce the effort required to deploy a solution at a second site. These results would provide a basis for deciding what to extend more widely.

How Deloitte can help

Turning digital health innovation into a viable product calls for more than a strong idea. It requires choices about where to compete, whom to serve and how to bring the product to market.

Deloitte partners with innovative companies to navigate those choices, shape commercial strategies and prepare for their next stage of growth, by bringing a practical perspective to decisions along the way.

Explore how the above three priorities apply to your organisation. 

This report, written jointly by BioAlps—Swiss Health Valley and Deloitte AG, examines how digital innovation can help address some of healthcare’s major challenges, and what is needed to translate its potential into routine care. It focuses on Western Switzerland as a geographically contained setting where research institutions, healthcare providers, technology companies and innovation support organisations operate in close proximity. For the purposes of this report, Western Switzerland comprises the following six cantons: Geneva, Vaud, Valais, Fribourg, Neuchâtel and Jura.

The analysis combines ecosystem mapping, publicly available research and market data, and interviews with leaders from seven companies and institutions. It first examines the forces reshaping digital health, then explores Western Switzerland’s considerable capabilities in four major health technology trends. Drawing on these findings and industry perspectives, the report identifies three priorities for the region: interoperability, scalability, and collaboration.

While grounded in Western Switzerland, these recommendations offer lessons for other healthcare ecosystems seeking to connect innovation with clinical needs, establish adoption pathways and support wider deployment.

Unlocking the new window for Digital health in the Swiss Health Valley

BioAlps and Deloitte examine the region’s digital health landscape and four emerging trends: wearables, clinical AI, genomics and multimodal data, and neurotechnology.

Did you find this useful?

Thanks for your feedback